| 136 | 8 | 6 |
| 下载次数 | 被引频次 | 阅读次数 |
目的分析原发性肝癌超声引导下射频消融术后复发的相关危险因素。方法选取2016年1月—2019年12月100例在新疆医科大学第一附属医院行射频消融术治疗的肝癌患者,随访3年观察入选患者复发情况,并根据患者有无复发分为复发组与对照组,采用单因素分析法和多因素分析法分析造成患者术后复发的相关因素。结果超声随访观察3年,共有16例患者复发,总复发率为16.0%。单因素分析结果显示:肝功能分级、病灶数目、病灶大小、消融范围等因素是造成患者术后复发的相关因素(P<0.05)。多因素分析结果显示,病灶数目、病灶大小、消融范围是患者术后复发的独立危险因素(P<0.05)。结论超声引导下射频消融术治疗原发性肝癌具有较好的远期疗效。而术后复发与肝功能分级、病灶数目、病灶大小、消融范围有密切相关性。
Abstract：Objective: To analyze the related risk factors of recurrence after ultrasound-guided radiofrequency ablation of primary liver cancer. Methods: From January 2016 to December 2019, 100 patients with liver cancer treated by radiofrequency ablation were selected, who followed up for 3 years to observe their recurrence. The patients were divided into recurrence group and control group. Single factor analysis and multifactor analysis were used to analyze the related factors of postoperative recurrence. Results: A total of 16 cases were found to recur after 3 years of ultrasound follow-up, with the total recurrence rate was 16.0%. Through univariate analysis, liver function grade, number of lesions, size of lesions, ablation range and other factors are related to postoperative recurrence(P<0.05). Through a multifactorial analysis, lesion number, lesion size, ablation range were independent risk factors for postoperative recurrence(P<0.05). Conclusion: Ultrasound-guided radiofrequency ablation is effective in the treatment of liver cancer. However, postoperative recurrence was closely related to liver function grade, number of lesions, size of lesions and ablation range.
[1]黄韬,钟鉴宏,齐亚鹏,等.术后复发性肝癌和原发性肝癌射频消融的临床疗效比较[J].中华普通外科杂志,2019,34(11):936-939.
[2]祁飞,夏春燕.预测原发性肝癌肝移植术后复发转移分子生物标志物的研究进展[J].山东医药,2020,60(2):85-88.
[3] SELBY LV, EJAZ A, BRETHAUER SA, et al. Fatty liver disease and primary liver cancer:disease mechanisms, emerging therapies and the role of bariatric surgery[J]. Espert Opin Inv Drug,2020,29(2):107-110.
[4] PARIZADEH SM, PARUZADEH SA, ALIZADE-NOGHANI M, et al. Association between non-alcoholic fatty liver disease and colorectal cancer[J].Expert Rev Gastroent,2019,13(7):633-641.
[5] NAKAMOTO R,OKUYAMA C,ISHIZU K, et al.diffusely decreased liver uptake on FDG PET and cancer-associated cachexia with reduced survival[J].Clin Nutrcancer,2019,44(8):634-642.
[6] TRAN KT,COLEMAN HG,MCCAIN RS, et al.Serum biomarkers of iron status and risk of primary liver cancer:a systematic review and Meta-analysis[J].Nutrcancer,2019,71(8):1365-1373.
[7] ENGEL LS,ZABOR EC,SATAGOPAN J, et al.Prediagnostic serum organochlorine insecticide concentrations and primary liver cancer:A case–control study nested within two prospective cohorts[J].Int J Cancer,2019,145(9):2360-2371.
[8] WAKABAYASHI T, ABA Y, ITANO O, et al. Laparoscopic repeat liver resection after open liver resection:A comparative study from a single-centre[J].J Minim Access Surg,2020,16(1):59-65.
[9] FARAMAWI MF,JOHNSON ES.A case-cohort study to investigate the excess of liver cancer observed in workers in poultry slaughtering&processing plants[J].Nutr Cancer,2019,71(7):1118-1131.
[10] CASTVEN D,BECKER D,CZAUDERNA C, et al.Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identification[J].Int J Cancer,2019,144(11):2782-2794.
[11]杨树法,樊喜文,李平新.射频消融治疗肝癌近期疗效观察(附12例报告)[J].新疆医科大学学报,2008,31(11):1605-1607.
基本信息:
中图分类号:R735.7
引用信息:
[1]刘怡彬,高军喜,李智铭,等.超声引导下原发性肝癌射频消融术后复发相关因素[J].新疆医科大学学报,2021,44(07):835-837.
基金信息:
新疆维吾尔自治区科技支疆项目（2020E0271)
2021-07-15
2021-07-15